Thyroid-Induced Toxicity of Check-Point Inhibitors Immunotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer

Journal Title: Journal of Endocrinology and Diabetes - Year 2016, Vol 3, Issue 1

Abstract

Immunotherapy represents a new strategy in the fight against cancer diseases based on the key role that immune system plays to identify and destroy foreign or abnormal cells in the body, including tumor cells. Nowadays, two immune-checkpoint inhibitors with antitumor activity have been approved for treatment of advanced nonsmall cell lung cancer (NSCLC): Nivolumab and Pembrolizumab (antiprogrammed death 1, anti-PD-1). However, these inhibitors are related to a unique class of mechanism-based toxicities, termed immunerelated Adverse Events (irAEs) that have an autoimmune etiology. Among endocrinopathies due to immuno-checkpoint antibodies, the thyreopathies are frequently reported, probably because antithyroid autoimmunity represents the most common autoimmune disease in humans. The spectrum of thyreopathies reported in NSCLC patients during therapy with immune-checkpoint inhibitors includes: thyroiditis, primary and secondary hypothyroidism and hyperthyroidism. In view of the ongoing increased employment of these drugs in the treatment of NSCLC, irAEs, described in selected patients in clinical trials, will began more frequent and with different clinical impact in routine practice. This manuscript focuses particularly on thyroid disorders induced by immunotherapies employed in NSCLC, in order to suggest the strategies for identify, diagnose and treat them without affecting patient outcomes.

Authors and Affiliations

Cesare Gridelli, Emanuela Rossi, Assunta Sgambato, Giovanni De Chiara, Fortunato Ciardiello

Keywords

Related Articles

Outcome of Patients with Diabetic Ketoacidosis in South of Iran

Introduction: Diabetic Keto acidosis (DKA) is the most common cause of mortality in children with diabetes mellitus. The aim of this study is to investigate the complications of DKA and its complications in hospitalized...

Measurements of Visceral Adiposity, Type-2 Diabetes and Risk for Cardiovascular Disease among Brazilian Men and Women

Background/aims: To detect a possible association between Visceral Adiposity Index (VAI), Lipid Accumulation Product Index (LAP) and equations to estimate Deep-Abdominal-Adipose- Tissue (DAAT) with type-2 diabetes mellit...

Trends of Thyroid Cancer Mortality Rates in Ecuador

Objective: To analyze thyroid cancer (TC) mortality rates from 1990 to 2016 in Ecuadorian men and women and compare their trends with Latin American and international trends. Design: A population-based temporal-trend st...

Sympathetic Voltage-Independent Regulation of Voltage- Gated Calcium Channels in Pancreatic β-Cells

Voltage-gated calcium (CaV) channels are regulated by G proteins via voltage-dependent and independent pathways. Voltage-independent regulation of calcium channels is important for intracellular calcium concentration and...

Social Determinants Related to Type 2 Diabetes Self-Care and Control Measures

Introduction: Diabetes Mellitus (DM) as a common metabolic disorder, is a controllable disease by the self-care and maintaining the blood sugar. This study is designed to investigate the social determinants of diabetes s...

Download PDF file
  • EP ID EP333392
  • DOI 10.15226/2374-6890/3/1/00143
  • Views 146
  • Downloads 0

How To Cite

Cesare Gridelli, Emanuela Rossi, Assunta Sgambato, Giovanni De Chiara, Fortunato Ciardiello (2016). Thyroid-Induced Toxicity of Check-Point Inhibitors Immunotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer. Journal of Endocrinology and Diabetes, 3(1), 1-10. https://www.europub.co.uk/articles/-A-333392